Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2024 09:00 ET | Source: CERo Therapeutics, Inc.

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation of...
March 18, 2020 11:00 ET | Source: CERo Therapeutics, Inc.

CERo Therapeutics Announces Research Collaboration with Lyell Immunopharma and Completion of Series A Financing

-- Research Collaboration to Develop Next Generation Cell-based Therapies for Solid Tumors -- -- $40 Million Raised by CERo to Facilitate Preclinical and Clinical Development -- SOUTH SAN...